Literature DB >> 25704318

Peripheral Lesions Identified on Ultrawide Field Imaging Predict Increased Risk of Diabetic Retinopathy Progression over 4 Years.

Paolo S Silva1, Jerry D Cavallerano2, Nour Maya N Haddad3, Hanna Kwak3, Kelli H Dyer3, Ahmed F Omar4, Hasanain Shikari3, Lloyd M Aiello2, Jennifer K Sun2, Lloyd Paul Aiello2.   

Abstract

OBJECTIVE: To determine whether peripheral diabetic retinopathy (DR) lesions identified on ultrawide field (UWF) imaging are associated with increased DR progression.
DESIGN: Prospective, longitudinal cohort. PARTICIPANTS: Two hundred eyes of 100 participants previously enrolled in a comparative instrument validation study.
METHODS: Baseline mydriatic 7-standard field Early Treatment Diabetic Retinopathy Study (ETDRS) photographs and UWF images were obtained. On UWF images, DR lesions with a greater extent outside versus inside standard ETDRS fields were defined as predominantly peripheral lesions (PPLs). Follow-up ETDRS photographs were obtained 4.2±0.3 years after baseline. Baseline and follow-up DR severity were graded from ETDRS photographs. MAIN OUTCOME MEASURES: Rates of 2-step or more progression and progression to proliferative DR (PDR) in eyes with PPLs compared with eyes without PPLs identified on UWF imaging at baseline.
RESULTS: In eyes without PDR (n = 109) at baseline, 56 (51%) had at least 1 field with PPLs and 43 (39%) had DR progression. Compared with eyes without PPLs, eyes with PPLs had a 3.2-fold increased risk of 2-step or more DR progression (6 [11%] vs. 19 [34%]; P = 0.005) and a 4.7-fold increased risk for progression to PDR (3 [6%] vs. 14 [25%]; P = 0.005). These findings remained statistically significant after adjusting for gender, diabetes type, diabetes duration, hemoglobin A1c (HbA1c) levels, and baseline DR severity. Increasing extent of fields with PPLs increased the risk for 2-step or more DR progression (P = 0.004) and progression to PDR (P = 0.009).
CONCLUSIONS: Presence and increasing extent of PPLs were associated with increased risk of DR progression over 4 years, independent of baseline DR severity and HbA1c levels. Increasing extent of PPLs substantially increased the risk of DR progression and progression to PDR, especially with less severe DR at baseline. These findings demonstrate that detailed peripheral retinal evaluation provides important information that is necessary to assess completely the risk of DR progression.
Copyright © 2015 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25704318     DOI: 10.1016/j.ophtha.2015.01.008

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  77 in total

1.  Advanced image processing for optical coherence tomographic angiography of macular diseases.

Authors:  Miao Zhang; Jie Wang; Alex D Pechauer; Thomas S Hwang; Simon S Gao; Liang Liu; Li Liu; Steven T Bailey; David J Wilson; David Huang; Yali Jia
Journal:  Biomed Opt Express       Date:  2015-11-02       Impact factor: 3.732

2.  Quantification of Retinal Nonperfusion and Neovascularization With Ultrawidefield Fluorescein Angiography in Patients With Diabetes and Associated Characteristics of Advanced Disease.

Authors:  Gina Yu; Michael T Aaberg; Tapan P Patel; Rahul S Iyengar; Corey Powell; Annie Tran; Caitlin Miranda; Emma Young; Katarina Demetriou; Laxmi Devisetty; Yannis M Paulus
Journal:  JAMA Ophthalmol       Date:  2020-06-01       Impact factor: 7.389

3.  Wide-field optical coherence tomography angiography for the detection of proliferative diabetic retinopathy.

Authors:  Francesco Pichi; Scott D Smith; Emad B Abboud; Piergiorgio Neri; Elizabeth Woodstock; Steven Hay; Emily Levine; Caroline R Baumal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-05-30       Impact factor: 3.117

4.  Peripheral Retinal Imaging Biomarkers for Alzheimer's Disease: A Pilot Study.

Authors:  Lajos Csincsik; Thomas J MacGillivray; Erin Flynn; Enrico Pellegrini; Giorgos Papanastasiou; Neda Barzegar-Befroei; Adrienne Csutak; Alan C Bird; Craig W Ritchie; Tunde Peto; Imre Lengyel
Journal:  Ophthalmic Res       Date:  2018-04-05       Impact factor: 2.892

5.  Distribution of peripheral lesions identified by mydriatic ultra-wide field fundus imaging in diabetic retinopathy.

Authors:  Aditya Verma; Ahmed Roshdy Alagorie; Kim Ramasamy; Jano van Hemert; N K Yadav; Rajeev R Pappuru; Adnan Tufail; Muneesawar Gupta Nittala; SriniVas R Sadda; Rajiv Raman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-01-27       Impact factor: 3.117

6.  Accuracy of ultrawide-field fundus ophthalmoscopy-assisted deep learning for detecting treatment-naïve proliferative diabetic retinopathy.

Authors:  Toshihiko Nagasawa; Hitoshi Tabuchi; Hiroki Masumoto; Hiroki Enno; Masanori Niki; Zaigen Ohara; Yuki Yoshizumi; Hideharu Ohsugi; Yoshinori Mitamura
Journal:  Int Ophthalmol       Date:  2019-02-23       Impact factor: 2.031

7.  Simultaneous multimodal ophthalmic imaging using swept-source spectrally encoded scanning laser ophthalmoscopy and optical coherence tomography.

Authors:  Joseph D Malone; Mohamed T El-Haddad; Ivan Bozic; Logan A Tye; Lucas Majeau; Nicolas Godbout; Andrew M Rollins; Caroline Boudoux; Karen M Joos; Shriji N Patel; Yuankai K Tao
Journal:  Biomed Opt Express       Date:  2016-12-12       Impact factor: 3.732

Review 8.  Diabetic retinopathy: current understanding, mechanisms, and treatment strategies.

Authors:  Elia J Duh; Jennifer K Sun; Alan W Stitt
Journal:  JCI Insight       Date:  2017-07-20

9.  Influencing factors for peripheral and posterior lesions in mild non-proliferative diabetic retinopathy-the Kailuan Eye Study.

Authors:  Mo-Chi Yang; Xiao-Bo Zhu; Ya-Xing Wang; Shou-Ling Wu; Qian Wang; Yan-Ni Yan; Xuan Yang; Jing-Yan Yang; Meng-Xi Chen; Ya-Hui Lei; Wen-Bin Wei
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

10.  Effects of motion and b-value on apparent temperature measurement by diffusion-based thermometry MRI: eye vitreous study.

Authors:  Jamal J Derakhshan; Neda Parvin; Laurie A Loevner; Felix W Wehrli; Robert C McKinstry
Journal:  Med Phys       Date:  2020-09-02       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.